Medical management of critical limb ischaemia: where do we stand today?

Keyphrases

• Critical Limb Ischemia 100%
• Medical Management 100%
• Randomized Controlled Trial 33%
• Cardiovascular Risk 33%
• Peripheral Arterial Disease 33%
• Diabetes Management 16%
• Stem Cells 16%
• Risk Reduction 16%
• Mortality Rate 16%
• Quality of Life 16%
• Cardiovascular Events 16%
• Severe Disease 16%
• Myocardial Infarction 16%
• Anticoagulation 16%
• Absence of Evidence 16%
• Disease Progression 16%
• Ulcer 16%
• Aspirin 16%
• Ulcer Healing 16%
• Major Amputation 16%
• Warfarin 16%
• Smoking Cessation 16%
• Hypertension Management 16%
• Follow-up Data 16%
• Heparin 16%
• Antiplatelet Agents 16%
• Clopidogrel 16%
• Rest Pain 16%
• Surgical Intervention 16%
• Hyperbaric Oxygen 16%
• Prostanoids 16%
• Iloprost 16%
• Thrombolysis 16%
• Arterial Occlusion 16%
• Ischemic Pain 16%
• Limb Loss 16%
• Pentoxifylline 16%
• Naftidrofuryl 16%
• Cilostazol 16%
• Death from Cardiovascular Diseases 16%
• Phase I Study 16%
• Endovascular Techniques 16%
• Smoking Treatment 16%
• Allreduce 16%
• Angiogenic Growth Factors 16%
• Acute Limb Ischemia 16%

Medicine and Dentistry

• Critical Limb Ischemia 100%
• Limb 42%
• Randomized Controlled Trial 28%
• Arteriosclerosis Obliterans 28%
• Stem Cell 14%
• Growth Factor 14%
• Surgery 14%
• Cardiovascular Risk 14%
• Mortality Rate 14%
• Diabetes 14%
• Cardiovascular System 14%
• Disease Exacerbation 14%
• Myocardial Infarction 14%
• Apoplexy 14%
• Cardiovascular Disease 14%
• Hyperlipidemia 14%
• Quality of Life 14%
• Acetylsalicylic Acid 14%
• Amputation 14%
• Ulcer Healing 14%
• Ulcer 14%
• Artery Occlusion 14%
• Warfarin 14%
• Prostaglandin 14%
• Antiplatelet Drug 14%
• Rest Pain 14%
• Nicotine Withdrawal 14%
• Anticoagulation 14%
• Hyperbaric Medicine 14%
• Heparin 14%
• Iloprost 14%
• Blood Clot Lysis 14%
• Clopidogrel 14%
• Naftidrofuryl 14%
• Pentoxifylline 14%
• Cilostazol 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Critical Limb Ischemia 100%
• Randomized Controlled Trial 28%
• Peripheral Occlusive Artery Disease 28%
• Growth Factor 14%
• Heart Infarction 14%
• Disease Exacerbation 14%
• Hyperlipidemia 14%
• Cerebrovascular Accident 14%
• Ulcer 14%
• Acetylsalicylic Acid 14%
• Mortality Rate 14%
• Artery Occlusion 14%
• Cardiovascular Risk 14%
• Warfarin 14%
• Prostaglandin 14%
• Clopidogrel 14%
• Antithrombocytic Agent 14%
• Ulcer Healing 14%
• Iloprost 14%
• Heparin 14%
• Pentoxifylline 14%
• Naftidrofuryl 14%
• Cilostazol 14%
• Cardiovascular Disease 14%